SCHEMBL4750797

SCHEMBL4750797

Cc1cccc(CCCOCCOC(=O)N2CCNCC2)n1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM5 P41594 6/20 0.41
CYP1A2 P05177 5/20 0.41
CYP3A4 P08684 4/20 0.41
PPARG P37231 1/20 0.39
GABRA1 P14867 1/20 0.37
GABRG2 P18507 1/20 0.37
GABRB3 P28472 1/20 0.37
GABRA5 P31644 1/20 0.37
GABRA3 P34903 1/20 0.37
GABRA2 P47869 1/20 0.37
DPP4 P27487 1/20 0.37
KMT2A Q03164 2/20 0.36
KDM4E B2RXH2 3/20 0.36
MEN1 O00255 1/20 0.36
CACNA1C Q13936 1/20 0.36
SCN5A Q14524 1/20 0.36
CHEK1 O14757 1/20 0.36
KCNH2 Q12809 2/20 0.35
CYP2D6 P10635 1/20 0.35
CYP2C19 P33261 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4753119 0.94 GRM5 (0.42) GRM5CYP1A2CYP3A4GABRA1GABRG2
SCHEMBL4751002 0.82 ALDH1A1 (0.47) GRM5CYP1A2CYP3A4KMT2AKDM4E
SCHEMBL4750792 0.78 POLB (0.52) CYP1A2PPARGGABRA1GABRG2GABRB3
SCHEMBL4751028 0.78 ALDH1A1 (0.45) KMT2AKDM4EALDH1A1POLBMAPT
SCHEMBL4753147 0.77 ALDH1A1 (0.45) PPARGKMT2AKDM4EMEN1KCNH2
SCHEMBL4750996 0.77 ALDH1A1 (0.45) CYP1A2KMT2AKDM4EMEN1KCNH2
SCHEMBL4753160 0.76 ALDH1A1 (0.50) GRM5CYP1A2CYP3A4KMT2AKDM4E
SCHEMBL22838001 0.73 ALDH1A1 (0.44) KMT2AMEN1ALDH1A1POLBGAA
SCHEMBL4750772 0.73 ALDH1A1 (0.45) PPARGKMT2AKDM4EMEN1ALDH1A1
SCHEMBL4752742 0.72 PPARG (0.41) PPARGGABRA1GABRG2GABRB3GABRA5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008147864-A2 METHODS OF USING PIPERAZINE COMPOUNDS IN TREATING SODIUM CHANNEL-MEDIATED DISEASES OR CONDITIONS XENON PHARMACEUTICALS INC. (CA) 2008-12-04 WO disclosed